Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James J. Ferguson III currently holds 135,000 shares of Mineralys Therapeutics, Inc. (MLYS), valued at approximately $0. This represents their equity stake as Chief Medical Officer.
Based on SEC Form 4 filings, James J. Ferguson III has been a net neutral trader of MLYS stock. They have purchased $0 and sold $0 worth of shares.
James J. Ferguson III's most recent insider trade was on Aug 10, 2026, when they sold 135,000 shares at $0.00 per share.
James J. Ferguson III serves as Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS). They have executed 2 insider transactions totaling $0 over their tenure at the company.
James J. Ferguson III holds the position of Chief Medical Officer at Mineralys Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
James J. Ferguson III has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James J. Ferguson III was on Aug 10, 2026, when they purchased $0 worth of MLYS shares. This transaction involved 135,000 shares at N/A per share.
James J. Ferguson III currently owns 135,000 shares of Mineralys Therapeutics, Inc. (MLYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James J. Ferguson III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James J. Ferguson III has 2 Form 4 filings on record as an insider at Mineralys Therapeutics, Inc..
Set alerts for James J. Ferguson III and 40,000+ other insiders.